Canada Gairdner Awards recognize the world’s most accomplished researchers whose work is improving our understanding of human ...

A smart beta exchange traded fund, the iShares Biotechnology ETF (IBB) debuted on 02/05/2001, and offers broad exposure to the Health Care ETFs category of the market. What Are Smart Beta ETFs? The ...

The winners of this year’s Canadian science prizes are all based in the United States, where Trump-era cutbacks to research ...

Grégoire Froehlich, GSF Trader at Natixis Corporate & Investment Banking, said: "Clearing SFTs at Cboe Clear Europe enhances our capital efficiencies and reduces operational complexities associated ...

So, if you look at the yearly free cash flow of the 10 largest pharmaceutical companies, this is a lot of dry powder for acquisitions. The term “top” is rather subjective, as is here a mix of existing ...

Instead, we used a more subjective (but more relevant) mix ... products in 9 different therapeutic areas. 10 products are in phase III clinical trials, 9 in phase II, and 21 in phase I. The Q4 2022 ...

Vertex Pharmaceuticals has grown from a $7.5 billion market cap to over $120 billion as it’s commercialized several products.

Investors seeking relief from the stock market turbulence at the start of 2025 should take a close look at Vertex ...

Over the past 15 years, Vertex Pharmaceuticals has grown from a $7.5 billion market cap to over $120 billion as it’s commercialized several products. CRISPR Therapeutics won its first regulatory ...

Investors seeking relief from the stock market turbulence at the start of 2025 should take a close look at Vertex Pharmaceuticals ... its existing portfolio of products while moving forward ...